SOFOCURE L SOFOSBUVIR AND LEDIPASVIR TABLETS

Get a Price/Quote

SOFOCURE L SOFOSBUVIR AND LEDIPASVIR TABLETS Specification

Indication
Chronic Hepatitis C Virus (HCV) infection

Grade
Pharmaceutical Grade

CAS No
1190307-88-0 (Sofosbuvir), 1256388-51-8 (Ledipasvir)

Usage
For the treatment of chronic hepatitis C infection

Molecular Formula
Sofosbuvir: C22H29FN3O9P; Ledipasvir: C49H54N8O6

Medicine Type
Allopathic

Dosage Form
Tablet

Dosage
400 mg Sofosbuvir + 90 mg Ledipasvir

Appearance
Film-coated tablets

Assay
Not less than 98% (as per label claim)

Expiration Date
36 months from manufacturing date

Storage
Store below 30C, protect from moisture and light

Salt Composition
Sofosbuvir 400 mg + Ledipasvir 90 mg

Origin of Medicine
India

Pacakaging (Quantity Per Box)
28 tablets per box

SOFOCURE L SOFOSBUVIR AND LEDIPASVIR TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About SOFOCURE L SOFOSBUVIR AND LEDIPASVIR TABLETS

Sofocure L

Specifications:-

Brand Name : Sofocure L
Content : Sofosbuvir & Ledipasvir
Strength : Sofosbuvir 400mg & Ledipasvir 90 mg
Packing : Pack of 28 Tablets
Company :- Emcure
Brand Name:Sofocure L
Content :Sofosbuvir Ledipasvir
Strength:400mg 90 mg
Packing:1X28 Tablets
Type Tablets
Uses:Hepatitis C

Note :- Sofocure L Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. The Information Provided Here Is For General Educational Purposes Only And Does Not Constitute Medical Or Pharmaceutical Advice Which Should Be Sought From Qualified Medical And Pharmaceutical Advisers...........

Additional Information: Item Code: Sofocure L

Direct-Acting Antiviral Solution

SOFOCURE L combines Sofosbuvir and Ledipasvir to offer a modern approach for managing chronic hepatitis C infection. It targets specific HCV genotypes, delivering well-recognized efficacy for adult patients. The film-coated tablets are easy to administer and designed for daily oral use as per prescription.

Reliable Pharmaceutical Quality

Each batch of SOFOCURE L meets stringent pharmaceutical standards, ensuring an assay of no less than 98% for active ingredients. Packaged securely in moisture-resistant boxes, this medicine maintains potency for up to 36 months from the manufacturing date, assuring consistent quality throughout its shelf life.

Convenient and Safe Administration

SOFOCURE L is supplied in boxes of 28 tablets, supporting a month-long treatment regimen as directed by healthcare providers. The tablets should be stored below 30C and protected from moisture and light, making them suited for varied pharmacy and home environments.

FAQs of SOFOCURE L SOFOSBUVIR AND LEDIPASVIR TABLETS:

Q: How should SOFOCURE L tablets be taken?

A: SOFOCURE L tablets are administered orally once daily, as directed by your healthcare professional. It is important to follow the prescribed dosage and treatment duration for optimal efficacy.

Q: What is the main therapeutic use of SOFOCURE L?

A: SOFOCURE L is primarily used for the treatment of chronic Hepatitis C Virus (HCV) infection, specifically targeting genotypes 1, 4, 5, and 6 in adult patients.

Q: When should I start using SOFOCURE L?

A: Start SOFOCURE L only upon the prescription of a qualified physician who has confirmed the indication and appropriateness of the medication for your hepatitis C genotype and medical condition.

Q: Where should SOFOCURE L be stored?

A: Store SOFOCURE L below 30C in a dry place, protected from moisture and light, to preserve the integrity and efficacy of the tablets.

Q: What is the minimum order quantity for SOFOCURE L?

A: The minimum order quantity for SOFOCURE L is one box containing 28 film-coated tablets, suitable for a standard monthly treatment course.

Q: What benefits does SOFOCURE L offer over other treatments?

A: SOFOCURE L provides targeted antiviral action as a direct-acting antiviral agent, delivering high effectiveness against multiple HCV genotypes with a convenient once-daily oral dosing regimen.